$BAFN

BayFirst Financial Corp. (BAFN): Results of Operations and Financial Condition

BayFirst Financial Corp. (BAFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. bafn-20260714 0001649739 FALSE 0001649739 2026-07-14 2026-07-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported)

Original reporting
Published Jul 15, 2026, 8:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$BAFN
Bearish
medium confidence
Mentioned
$BAFN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BAFNBearishHigh
01

Why it matters

The company quantified portfolio measurement impacts ($37.0M) and additional impairment/write-down items, and it also disclosed misstatements that led to restating 2024, 2025, and 1Q26 results with non-reliance guidance. It will include these items in Q2 earnings and file amendments by Aug 12, while evaluating internal control material weaknesses and incentive compensation recovery.

02

Market read

This is a direct earnings-quality and reporting-reliability shock, with quantified portfolio impacts and explicit non-reliance on prior results, raising near-term valuation and volatility risk.

03

What to watch

Investors should separate the $37.0M asset resolution adjustments from the smaller restatement deltas, and watch whether management concludes no material weaknesses in internal controls.

Relevance 7/10Novelty 8/10Timing: Filed July 15. Q2 earnings after close July 30, amended filings expected by Aug 12.

Background

BayFirst Financial completed and quantified an asset resolution plan tied to transactions under a Stock Purchase Agreement dated April 28, 2026, and later identified accounting errors requiring restatements.

Company-level read

Ticker impact

$BAFNBearishMedium confidence
Context

BayFirst Financial disclosed a quantified $37.0M asset resolution impact and will restate 2024-1Q26 results, including net income and net loss corrections.

Expected impact

Near-term downside bias with elevated volatility into the July 30 Q2 earnings release and the August 12 amended filings deadline.

Evidence & confidence

The filing includes quantified impacts, non-reliance on prior statements, and potential internal control material weakness evaluation, which typically drives risk-off repricing for small-cap banks.

Market effects

Highlights heightened scrutiny of SBA/USDA loan accounting and CECL/ASC 326 measurement assumptions for small lenders.

Limited, but could affect investor sentiment toward Florida-based community bank peers with similar SBA exposure.

Low; primarily a single-issuer accounting and restatement event.

Counterpoint

The restatement may be largely accounting-driven from a known asset resolution plan, and the quantified impacts could reduce uncertainty once investors model the corrected earnings power.

Key entities

  • BayFirst Financial Corp.

    Nasdaq-listed community bank that disclosed quantified asset resolution impacts and restated prior financial statements via an 8-K.

  • Audit Committee of the Board of Directors

    Agreed that previously issued financial statements should no longer be relied upon for 2024, 2025, and 1Q26.

  • Forvis Mazars, LLP

    Independent registered public accounting firm with audit reports that will no longer be relied upon for the affected periods.

Related articles

$BAFNMedAI 8/10

BayFirst Announces Impact of Asset Resolution Plan and Restatement of Prior Period Financial Statements

BayFirst Financial Corp. (NASDAQ: BAFN) said it quantified an asset resolution plan tied to an April 28, 2026 stock purchase agreement, with $37.0 million of adjustments to SBA 7(a) and other loan balances, plus $1.5 million impairment and $1.6 million write-downs. It will restate 2024-2025 and Q1 2026 results due to $2.8 million deferred origination costs and $2.1 million accrued interest misstatements, and expects amended filings by Aug. 12, 2026.

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$ULSMed

UL Solutions Q2 Earnings Call Highlights

UL Solutions (NYSE:ULS) reported Q2 consumer revenue of $362M, up 6.5% (6.2% organic), with adjusted EBITDA rising 24.2% to $77M and margin up 310 bps to 21.3%. Risk and compliance revenue fell 17.5% to $52M after an April 1 EHS software divestiture. Operating cash flow and free cash flow for TTM were $678M and $436M. Guidance for 2026 was reaffirmed.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.